Nocion Therapeutics, Inc. — Form D/A

Nocion Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D amendment with the SEC on 2022-08-24. The offering totals $17.0M, of which $7.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
JESSICA M ALSTONDirectorWALTHAM, MA
MEREDITH M FISHERDirectorWALTHAM, MA
JULIE PAPANEK GRANTDirectorWALTHAM, MA
MICHAEL PAPANEK HIGGINSDirectorWALTHAM, MA
BRIDGET M COLEExecutive OfficerWALTHAM, MA
JAMES M ELLISExecutive OfficerWALTHAM, MA
JONATHAN PAPANEK GARENExecutive OfficerWALTHAM, MA
MICHAEL M LIPPExecutive OfficerWALTHAM, MA
CHRISTOPHER M SILBERExecutive OfficerWALTHAM, MA
James EllisExecutive OfficerWATERTOWN, MA
Matthew FrankelExecutive OfficerWATERTOWN, MA
JULIE GRANTDirectorWATERTOWN, MA
ROSY HUDirectorWATERTOWN, MA
BERNARD SILVERMANExecutive OfficerWATERTOWN, MA
RICHARD BATYCKYDirectorFRAMINGHAM, MA
RICHARD BATYCKYExecutive OfficerFRAMINGHAM, MA
FREDDIE DEARDirectorWATERTOWN, MA
PINI ORBACHDirectorWatertown, MA
PETER COUROSSIExecutive OfficerChicago, IL
MICHAEL HIGGINSDirectorFRAMINGHAM, MA
VIJAY MURTHYDirectorWATERTOWN, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2026-03-13D$23.0M$23.0M
2024-03-13D$70.0M$31.1M
2021-08-31D$17.0M$7.0M
2021-01-22D$25.0M$15.0M

More